AbstractRecent advances in ultrasound technology have made modern handheld ultrasound devices and are contributing to make bedside ultrasound evaluation a practice available to all physicians. A 46‐year‐old woman with history of systemic erythematosus presented to our hospital with 14 days of COVID‐19. The patient suddenly presented greater respiratory distress, tachycardia, hypotension, and increased supplemental oxygen requirements; so she required mechanical ventilation. Point‐of‐care ultrasound assessment with handheld ultrasound device was observed on the apical view an apical thrombus in the right ventricle, McConnell's sign. The patient underwent systemic thrombolysis with alteplase showing improvement in mechanical ventilation parameters and is currently continuing treatment for COVID‐19 in the intensive care unit of our hospital. Emerging technologies such as handheld ultrasound devices can provide high‐quality care to the patients. Routine screening of patients with COVID‐19 using handheld ultrasound is feasible, may be able to define prognosis and treatment of cardiovascular complications.